...
首页> 外文期刊>Journal of receptor and signal transduction research >C-type natriuretic peptide suppresses mesangial proliferation and matrix expression via a MMPs/TIMPs-independent pathway in vitro
【24h】

C-type natriuretic peptide suppresses mesangial proliferation and matrix expression via a MMPs/TIMPs-independent pathway in vitro

机译:C型利钠肽通过体外MMPS / TIMPS-无关的途径抑制髓显性增殖和基质表达

获取原文
获取原文并翻译 | 示例
           

摘要

C-type natriuretic peptide (CNP) acts mainly in a local, paracrine fashion to regulate vascular tone and cell proliferation. Although several in vivo studies have demonstrated that CNP exerts an inhibitory effect on mesangial matrix generation, a limited number of reports exist about the anti-extracellular matrix (ECM) accumulation effect of CNP and its underlying mechanisms in mesangial cells (MCs) in vitro. In this study, human MCs were incubated in serum-containing medium in the absence or presence of CNP (0, 10 and 100pM) for 24, 48 and 72h, respectively. CNP administration significantly suppresses MCs proliferation and collagen (Col)-IV expression in a time- and dose-dependent manner. In addition, the study presented herein was designed as a first demonstration of the regulative effects of CNP on the metabolisms of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in MCs in vitro, and found that: (1) CNP administration significantly decreased the secretion and expression of MMP-2 and MMP-9 in the cultured MCs; (2) the secretion and expression of TIMP-1 progressively elevated after treatment with CNP for 24 and 48h, whereas declined at later time point; (3) CNP expression was negatively correlated with MMP-2 and MMP-9 expression; (4) the balance of MMPs/TIMPs was shifted toward the reduction in MMP-2 and MMP-9 activity and/or the increment in TIMP-1 expression, which could not account for the down-regulation of Col-IV expression in CNP-treated MCs. In conclusion, CNP suppresses mesangial proliferation and ECM expression via a MMPs/TIMPs-independent pathway in vitro.
机译:C型Natrietic肽(CNP)主要以局部,帕拉卡碱的方式起作用,以调节血管间调和细胞增殖。虽然有几个体内研究表明,CNP对Mesangial基质产生的抑制作用,关于CNP的抗细胞外基质(ECM)积累效应的有限数量的报告及其在体外乳房细胞(MCS)中的潜在机制。在该研究中,将人MCS分别在含血清培养基中在没有或存在下的CNP(0,1100和100pm)中,分别为24,48和72h。 CNP管理显着抑制MCS增殖和胶原(COL)-IV表达以时间和剂量依赖性方式。此外,本文提出的研究被设计为CNP在体外MCS中基质金属蛋白酶(MMPS)和组织抑制剂(TIMP)中的基质金属蛋白酶(MMP)和组织抑制剂的第一次演示,发现:(1)CNP施用在培养的MCS中显着降低了MMP-2和MMP-9的分泌和表达; (2)用CNP处理24和48h处理后TiMP-1的分泌和表达,而在稍后的时间点下降; (3)CNP表达与MMP-2和MMP-9表达呈负相关; (4)MMPS / TIMPS的余额转向MMP-2和MMP-9的减少和/或TIMP-1表达中的增量,这无法解释CNP中COL-IV表达的下调-Treated MCS。总之,CNP通过体外MMPS / TIMPS-无关的途径抑制了Mesangial增殖和ECM表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号